Press release
Growth Dynamics on Secondary Hyperparathyroidism Treatment (SHPT) Market 2019-2026| Key Players : Amgen Inc. , Teva Pharmaceutical Industries Ltd. , Genzyme Corporation (Sanofi) , AbbVie Inc. , Cipla Inc. , Dr. Reddy's Laboratories Ltd. ,OPKO Health Inc.
Secondary Hyperparathyroidism Treatment (SHPT) Market
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664
The report covers :
o Global U.S. secondary hyperparathyroidism treatment market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast time frame.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.
An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
Please visit : https://www.fortunebusinessinsights.com/industry-reports/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664
Leading Players operating in the Secondary Hyperparathyroidism Treatment (SHPT) Market are :
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o Amgen Inc.
o Teva Pharmaceutical Industries Ltd.
o Genzyme Corporation (Sanofi)
o AbbVie Inc.
o Cipla Inc.
o Dr. Reddy's Laboratories Ltd.
o OPKO Health, Inc.
o Other Prominent Players
Emerging Guidelines By Government Authorities Will Boost Growth
The increasing government initiatives for improvising secondary hyperparathyroidism management will create growth opportunities for the secondary hyperparathyroidism treatment market. The aim of SHPT treatment is to manage the biochemical markers of bone and mineral metabolism, which are directly linked to cardiovascular events and bone fractures by extensive epidemiologic evidence. International & national organizations in the U.S. and working groups such as the National Kidney Foundation have published various clinical guidance documents to encourage best practices in managing SHPT. Furthermore, increasing awareness about SHPT in physicians, as well as clinical specialists, have improved the treatment regimen for its management. The improvement in earlier identification and assessment of SHPT for mineral metabolism in CKD & ESRD will have a positive impact on secondary hyperparathyroidism treatment market growth. The reduction in associated complications for the management of SHPT is expected to accelerate growth of the market during the forecast period.
Rising Prevalence Of Chronic Kidney Disease Will Stimulate Growth
The increasing prevalence of chronic kidney disease among geriatric population as well as general population will enable the growth of the secondary hyperparathyroidism treatment market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 15% of U.S adults, which, is, 37 million people are estimated to have chronic kidney disease. Additionally, CKD is found more common in people aged 65 years or older than in people aged 45-64 years. The rising cases of renal disease and increasing patient pool will have a significant impact on the market. The increasing cost burden for the treatment of secondary
hyperparathyroidism will further encourage growth of the market. In addition, the launch of generic form of Cinacalcet hydrochloride tablets will bode well for the secondary hyperparathyroidism treatment market. For instance, Cipla Inc. and its subsidiary Cipla USA Inc. announced the launch of a generic form of Cinacalcet hydrochloride tablets in USA. Moreover, Amgen Inc. announced the USFDA approval of Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD). The approval for Parsabiv will also aid the growth of the market during the forecast period.
Have Any Query? Ask Our Experts :
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growth Dynamics on Secondary Hyperparathyroidism Treatment (SHPT) Market 2019-2026| Key Players : Amgen Inc. , Teva Pharmaceutical Industries Ltd. , Genzyme Corporation (Sanofi) , AbbVie Inc. , Cipla Inc. , Dr. Reddy's Laboratories Ltd. ,OPKO Health Inc. here
News-ID: 2028209 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for SHPT
US Secondary Hyperparathyroidism Treatment (SHPT) Market is growing at a CAGR of …
In recent years, the US Secondary Hyperparathyroidism Treatment (SHPT) Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on US Secondary Hyperparathyroidism Treatment (SHPT) Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of…
US Secondary Hyperparathyroidism Treatment (SHPT) Market Size: Set to Reach USD …
In recent years, the global US Secondary Hyperparathyroidism Treatment (SHPT) Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on US Secondary Hyperparathyroidism Treatment (SHPT) Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Secondary Hyperparathyroidism (SHPT) Treatment Market Insights, Forecast to 2030
The report extensively examines the global Secondary Hyperparathyroidism (SHPT) Treatment market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Secondary Hyperparathyroidism (SHPT) Treatment . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers…
Secondary Hyperparathyroidism (SHPT) Treatment Market demand will reach a value …
Newark, New Castle, USA - Growth Plus Reports has published a comprehensive research report of the Secondary Hyperparathyroidism (SHPT) Treatment Market, which include a detailed study of the product offerings, advancements, applications, benefits, and scope. The report covers significant strategic developments in addition to R&D, launches of new products, acquisitions and mergers, partnerships, alliances, agreements, limited partnerships, and the regional growth of fundamental competitors operating at the global and…
Secondary Hyperparathyroidism (SHPT) Treatment Market Statistical Forecast, Trad …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Secondary Hyperparathyroidism (SHPT) Treatment, which includes a detailed analysis based on competitors and important market segments (2022-2030). The Global Secondary Hyperparathyroidism (SHPT) Treatment provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it…
(2022 - 2030) Secondary Hyperparathyroidism (SHPT) Treatment Market Insights, Fo …
A recent market research report added to repository of Growth Plus Reports is an in-depth analysis of global Secondary Hyperparathyroidism (SHPT) Treatment Market . On the basis of historic growth analysis and current scenario of Secondary Hyperparathyroidism (SHPT) Treatment Market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research.…
